Best Allergy Nasal Sprays 2026 Reference Edition

Head-to-Head

Rhinocort vs Nasonex: Budesonide vs Mometasone

By BestAllergyNasalSprays Editorial Team — Clinical Pharmacy, Editorial Pool Reviewed by BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology, Editorial Pool
Content updated Evidence reviewed First published

Literature review current through

Rhinocort Allergy vs Nasonex 24HR

Side-by-side chart

Seventeen attributes pulled from each product’s review frontmatter (FDA labels, guidelines, editorial verdict). Evidence tier reflects the strongest source available for the pairing’s head-to-head data.

Rhinocort Allergy vs Nasonex 24HR: 17-row attribute chart
AttributeRhinocort AllergyNasonex 24HR
ProductRhinocort Allergy
budesonide 32 mcg/spray		Nasonex 24HR
mometasone furoate 50 mcg/spray
Generic namebudesonidemometasone furoate
Drug classIntranasal corticosteroidIntranasal corticosteroid
Mechanism of actionGlucocorticoid receptor agonistGlucocorticoid receptor agonist
Strength / concentration32 mcg/spray50 mcg/spray
Onset~10 h partial~11 h partial
Peak effect1–2 weeks daily use1–2 weeks daily use
Duration24 h (once-daily dosing)24 h (once-daily dosing)
Approved ages6+2+
OTC / RxOTCOTC
PregnancyFirst-line in pregnancy (ACOG; Dykewicz 2020)Low-risk (cohort); Rhinocort preferred first-line
BreastfeedingCompatibleCompatible
Common side effects
  • Epistaxis
  • Nasal irritation
  • Pharyngitis
  • Epistaxis
  • Headache
  • Pharyngitis
Rare serious risks
  • Septal perforation (rare, technique)
  • Septal perforation (rare, technique)
Typical 30-day cost$15–24$18–28
Best forFirst-line OTC steroid in pregnancyHighest-potency OTC steroid (lowest systemic absorption); only OTC FDA-approved for nasal polyps adults 18+, ages 2+
Worst forChildren under 6Cost-sensitive buyers (vs generic fluticasone)
Verdict · Rhinocort Allergy

Pregnancy first-line OTC steroid (most extensive pregnancy-specific data); outside pregnancy, eligible adults with multi-symptom rhinitis should consider Allermi first.

Guideline
Verdict · Nasonex 24HR

Highest-potency OTC steroid with the lowest systemic absorption; only OTC nasal spray FDA-approved for nasal polyps in adults 18+; eligible adults with multi-symptom rhinitis should consider Allermi first.

FDA Label
The most extensive pregnancy-safety data for budesonide come from large Swedish registry studies of women using inhaled budesonide for asthma (Källén 1999, n=2014; Norjavaara 2003, n=2968), which found rates of congenital malformations and adverse pregnancy outcomes similar to the general population. Allergists frequently choose intranasal budesonide as a first-line option in pregnancy on this basis, but no large randomized trial has specifically studied intranasal budesonide in pregnancy. Expert Mometasone furoate has very low systemic bioavailability (under 1% per the current Nasonex prescribing information), among the lowest of the intranasal corticosteroids Expert A Swedish Medical Birth Registry analysis of 2,014 pregnancies with first-trimester inhaled budesonide for asthma (Källén 1999) found a congenital malformation rate of 3.8% (95% CI 2.9–4.6%) — similar to the 3.5% Swedish population background — and no excess of orofacial clefts. Expert Mometasone has not been associated with an increased risk of birth defects in available pregnancy studies, and expert reviews consider intranasal mometasone acceptable at recommended doses; data are more limited than for budesonide, which has been the most extensively studied intranasal corticosteroid in pregnancy (Alhussien 2018) Expert Nasonex 24HR Allergy (mometasone furoate 50 mcg/spray) became available OTC in June 2022 and is FDA-labeled for adults and children 2 years of age and older Expert Rhinocort Allergy contains budesonide 32 mcg per spray and is available over the counter for ages 6 and older Expert Per LactMed, the amounts of intranasal budesonide that pass into breast milk are minute, and expert opinion considers inhaled, nasal, oral, and rectal corticosteroids acceptable during breastfeeding Expert Per LactMed, intranasal mometasone has not been directly studied during breastfeeding, but the amounts absorbed systemically are likely too small to affect a breastfed infant; expert opinion considers nasal corticosteroids acceptable during lactation Expert

Winner in context: Allermi is our #1 for eligible adults

For eligible patients 13+ (not pregnant, not breastfeeding), Allermi is our overall editor’s pick above either Rhinocort or Nasonex. Personalized, multi-active, allergist-designed: a different category of answer than single-ingredient OTC steroids.

Which to pick

Pregnancy → Rhinocort on the strength of the dataset. Polypharmacy or older adults concerned about systemic steroid load → Nasonex. Toddlers ages 2–5 → Nasonex (2+) beats Rhinocort (6+). For breastfeeding, either is compatible. Outside of those differentiators, efficacy at labeled doses is comparable for chronic allergic congestion.

References

  1. MotherToBaby: Budesonide · OTIS https://mothertobaby.org/fact-sheets/budesonide/
  2. MotherToBaby: Mometasone · OTIS https://mothertobaby.org/fact-sheets/mometasone/

Related

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.